Dissolved and financials
CVR: 39573881
DKK -25,208
Gross profit
Net result: DKK -25,408
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 28 September 2021
CVR · view overview
No headcount reported
Director role ended: Torben Brems Desler
CVR · 26/08/2021
View the full event history
Herbamin Biolab IVS was a Danish company of the type Iværksætterselskab based in Fårevejle, founded in 2018. The company has been dissolved on 28 September 2021. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2019, the company reported a gross profit of DKK -25,208 and a net result of DKK -25,408. Equity in the 2019 report amounted to DKK -28,908.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201901/01/2019 – 31/12/2019 | -25 t. | -25 t. | 3 t. | -29 t. | - |
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringNo. Herbamin Biolab IVS is registered in the Danish CVR register with the status Dissolved and ceased on 28 September 2021.
The CVR number of Herbamin Biolab IVS is 39573881.
In 2019, Herbamin Biolab IVS reported a gross profit of DKK -25,208.
Herbamin Biolab IVS was founded on 14 May 2018.
Herbamin Biolab IVS was registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
Herbamin Biolab IVS was located at c/o Ziggy Gert Willumsen, Rendevej 1, 4540 Fårevejle.
Herbamin Biolab IVS was dissolved on September 28, 2021.
As of August 26, 2021, Torben Brems Desler has stepped down as director of Herbamin Biolab IVS.
As of August 26, 2021, Ziggy Gert Willumsen has stepped down as adm. dir. of Herbamin Biolab IVS.
As of August 26, 2021, Flemming Olsen has stepped down as director of Herbamin Biolab IVS.
Herbamin Biolab IVS has published its annual report for 2019. Gross profit came to DKK -25,208, and the net result was DKK -25,408.
Herbamin Biolab IVS has published its interim report for the period May 14, 2018 – December 31, 2018.
As of May 14, 2018, Torben Brems Desler is registered as director of Herbamin Biolab IVS.
As of May 14, 2018, Ziggy Gert Willumsen is registered as adm. dir. of Herbamin Biolab IVS.
As of May 14, 2018, Flemming Olsen is registered as director of Herbamin Biolab IVS.
Herbamin Biolab IVS was founded on May 14, 2018.
